PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

This data tracks five-year relative survival rates for lung cancer based on how far the cancer has spread. Generally speaking, the earlier your cancer is diagnosed, the greater the chances it can be ...

than high-dose-rate brachytherapy (HDR-BT) for radio-recurrent prostate cancer. Local salvage therapy is rarely used, despite the fact that local tumor persistence following external beam radiation ...

Platelet-to-lymphocyte ratio as a useful biomarker of recurrence and mortality risks in patients with muscle-invasive bladder cancer who achieved ypT0 to neoadjuvant chemotherapy: A multicenter ...

Data taken from [3]. Epidemiologic evidence suggests that anesthetic choice may make a difference in tumor recurrence in breast and prostate cancer. This article proposes oncogenic effects of ...

Oct. 30, 2024 — Metastasis remains the primary challenge to reducing cancer deaths worldwide. A study is providing insights that researchers say point to therapeutic ... Determining Precise ...

Patients with relapse-onset MS who have been stable for at least 5 years on DMT have a higher risk of recurrence if they ... The study also reported similar rates of adverse events between the ...

To date, the fund has raised over £1.4m. Robert Swannell said: “When Patricia and I embarked on this mission we were astonished to find that so little was known about the science of dormancy and late ...

Thousands of people are dying needlessly from cancer in the UK because it is lagging behind other countries in earlier detection rates, according to Cancer Research UK. The finding is laid out in ...

Data from All 50 States Shows Early Onset Breast Cancer Is on the Rise in Younger Women: Does Place of Exposure Matter? Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary ...

Prognostic significance of PSA in the outcomes of patients with high risk localized prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract ...